RMB Capital Management LLC Sells 3,190 Shares of Omnicell, Inc. (OMCL)

RMB Capital Management LLC trimmed its stake in shares of Omnicell, Inc. (NASDAQ:OMCL) by 11.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,638 shares of the company’s stock after selling 3,190 shares during the quarter. RMB Capital Management LLC’s holdings in Omnicell were worth $1,570,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in Omnicell by 27.9% during the 3rd quarter. Vanguard Group Inc. now owns 3,806,211 shares of the company’s stock worth $273,665,000 after acquiring an additional 830,338 shares during the period. Fox Run Management L.L.C. acquired a new stake in Omnicell during the 4th quarter worth approximately $372,000. Teton Advisors Inc. lifted its position in Omnicell by 1.6% during the 4th quarter. Teton Advisors Inc. now owns 63,677 shares of the company’s stock worth $3,900,000 after acquiring an additional 1,000 shares during the period. BlackRock Inc. raised its stake in shares of Omnicell by 5.9% during the 3rd quarter. BlackRock Inc. now owns 5,903,099 shares of the company’s stock worth $424,432,000 after buying an additional 327,747 shares in the last quarter. Finally, Comerica Bank raised its stake in shares of Omnicell by 1.2% during the 4th quarter. Comerica Bank now owns 74,551 shares of the company’s stock worth $4,685,000 after buying an additional 866 shares in the last quarter.

In related news, Chairman Randall A. Lipps sold 9,482 shares of the firm’s stock in a transaction that occurred on Tuesday, December 18th. The stock was sold at an average price of $63.89, for a total value of $605,804.98. Following the completion of the transaction, the chairman now directly owns 165,025 shares of the company’s stock, valued at approximately $10,543,447.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Peter J. Kuipers sold 2,429 shares of the firm’s stock in a transaction that occurred on Tuesday, December 18th. The shares were sold at an average price of $64.18, for a total value of $155,893.22. Following the completion of the transaction, the insider now directly owns 47,814 shares of the company’s stock, valued at $3,068,702.52. The disclosure for this sale can be found here. Insiders sold a total of 102,700 shares of company stock valued at $8,111,430 over the last ninety days. 3.71% of the stock is currently owned by company insiders.

A number of equities analysts have recently issued reports on OMCL shares. Zacks Investment Research downgraded Omnicell from a “hold” rating to a “sell” rating in a research note on Friday, February 15th. Oppenheimer increased their target price on Omnicell to $86.00 and gave the stock an “outperform” rating in a research note on Friday, December 7th. Piper Jaffray Companies reissued a “neutral” rating and set a $70.00 target price on shares of Omnicell in a research note on Friday, February 8th. They noted that the move was a valuation call. Cantor Fitzgerald reissued an “overweight” rating and set a $80.00 target price (up from $70.00) on shares of Omnicell in a research note on Thursday, December 6th. Finally, BidaskClub raised Omnicell from a “hold” rating to a “buy” rating in a research note on Wednesday, February 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $76.56.

Shares of OMCL stock opened at $84.74 on Friday. Omnicell, Inc. has a 12-month low of $41.59 and a 12-month high of $86.87. The company has a market cap of $3.46 billion, a PE ratio of 55.39, a price-to-earnings-growth ratio of 3.91 and a beta of 1.25. The company has a quick ratio of 1.45, a current ratio of 1.94 and a debt-to-equity ratio of 0.20.

Omnicell (NASDAQ:OMCL) last released its quarterly earnings data on Thursday, February 7th. The company reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.16. Omnicell had a return on equity of 9.31% and a net margin of 4.79%. The firm had revenue of $211.75 million during the quarter, compared to the consensus estimate of $215.41 million. During the same period last year, the business posted $0.55 EPS. Omnicell’s quarterly revenue was up 7.8% on a year-over-year basis. On average, equities research analysts expect that Omnicell, Inc. will post 1.83 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “RMB Capital Management LLC Sells 3,190 Shares of Omnicell, Inc. (OMCL)” was first posted by WKRB News and is the property of of WKRB News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.wkrb13.com/2019/03/17/rmb-capital-management-llc-sells-3190-shares-of-omnicell-inc-omcl.html.

Omnicell Profile

Omnicell, Inc provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence. The Automation and Analytics segment offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.

Recommended Story: The components of the Stochastic Momentum Index

Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell, Inc. (NASDAQ:OMCL).

Institutional Ownership by Quarter for Omnicell (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.